241 related articles for article (PubMed ID: 26159921)
1. XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides.
Hori S; Yamamoto T; Obika S
Biochem Biophys Res Commun; 2015 Aug; 464(2):506-11. PubMed ID: 26159921
[TBL] [Abstract][Full Text] [Related]
2. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA.
Vickers TA; Crooke ST
Nucleic Acids Res; 2015 Oct; 43(18):8955-63. PubMed ID: 26384424
[TBL] [Abstract][Full Text] [Related]
3. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
Liang XH; Sun H; Nichols JG; Crooke ST
Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
[TBL] [Abstract][Full Text] [Related]
4. RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery.
Lima WF; De Hoyos CL; Liang XH; Crooke ST
Nucleic Acids Res; 2016 Apr; 44(7):3351-63. PubMed ID: 26843429
[TBL] [Abstract][Full Text] [Related]
5. Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination.
Lai F; Damle SS; Ling KK; Rigo F
Mol Cell; 2020 Mar; 77(5):1032-1043.e4. PubMed ID: 31924447
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms.
Vickers TA; Crooke ST
PLoS One; 2014; 9(10):e108625. PubMed ID: 25299183
[TBL] [Abstract][Full Text] [Related]
7. Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs.
Liang XH; Nichols JG; Sun H; Crooke ST
Nucleic Acids Res; 2018 Jan; 46(1):293-313. PubMed ID: 29165591
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.
Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP
Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810
[TBL] [Abstract][Full Text] [Related]
9. NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides.
Zhang L; Bernardo KD; Vickers TA; Tian J; Liang XH; Crooke ST
Nucleic Acid Ther; 2022 Aug; 32(4):280-299. PubMed ID: 35852833
[TBL] [Abstract][Full Text] [Related]
10. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.
Zhang L; Vickers TA; Sun H; Liang XH; Crooke ST
Nucleic Acids Res; 2021 Mar; 49(5):2721-2739. PubMed ID: 33577678
[TBL] [Abstract][Full Text] [Related]
11. Some ASOs that bind in the coding region of mRNAs and induce RNase H1 cleavage can cause increases in the pre-mRNAs that may blunt total activity.
Liang XH; Nichols JG; De Hoyos CL; Crooke ST
Nucleic Acids Res; 2020 Sep; 48(17):9840-9858. PubMed ID: 32870273
[TBL] [Abstract][Full Text] [Related]
12. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
[TBL] [Abstract][Full Text] [Related]
13. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.
Hasselblatt P; Hockenjos B; Thoma C; Blum HE; Offensperger WB
Nucleic Acids Res; 2005; 33(1):114-25. PubMed ID: 15640448
[TBL] [Abstract][Full Text] [Related]
14. Efficient and selective knockdown of small non-coding RNAs.
Liang XH; Shen W; Crooke ST
Methods Mol Biol; 2015; 1296():203-11. PubMed ID: 25791603
[TBL] [Abstract][Full Text] [Related]
15. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Lima WF; Crooke ST
Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.
Vickers TA; Rahdar M; Prakash TP; Crooke ST
Nucleic Acids Res; 2019 Nov; 47(20):10865-10880. PubMed ID: 31495875
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
Li Y; Yamane D; Lemon SM
J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
[TBL] [Abstract][Full Text] [Related]
18. The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides.
ten Asbroek AL; van Groenigen M; Nooij M; Baas F
Eur J Biochem; 2002 Jan; 269(2):583-92. PubMed ID: 11856317
[TBL] [Abstract][Full Text] [Related]
19. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
[TBL] [Abstract][Full Text] [Related]
20. mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway.
Liang XH; Nichols JG; Hsu CW; Vickers TA; Crooke ST
Nucleic Acids Res; 2019 Jul; 47(13):6900-6916. PubMed ID: 31165876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
